• Media type: E-Article
  • Title: Hepatitis C: When high drug prices preclude patient benefit
  • Contributor: Kantarjian, Hagop M.; Paul, Shilpa
  • Published: Wiley, 2018
  • Published in: Cancer, 124 (2018) 8, Seite 1644-1646
  • Language: English
  • DOI: 10.1002/cncr.31292
  • ISSN: 0008-543X; 1097-0142
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Description: <jats:p>Currently, there are at least 6 drug companies that have developed curative treatments for hepatitis C. Drugs that cure hepatitis C can save up to one‐half million individuals every year, but these therapies are neither accessible nor affordable. See also pages 1647‐49.</jats:p>
  • Access State: Open Access